By Research Area
Hot products 
-
Mouse Anti-ASH1L Monoclonal Antibody (ASH5H03) (CBMAB-1372-YC)
-
Rat Anti-EPO Recombinant Antibody (16) (CBMAB-E1578-FY)
-
Rabbit Anti-AP2M1 (Phosphorylated T156) Recombinant Antibody (D4F3) (PTM-CBMAB-0610LY)
-
Mouse Anti-Acetyl-α-Tubulin (Lys40) Recombinant Antibody (V2-623485) (CBMAB-CP2897-LY)
-
Mouse Anti-ACTB Recombinant Antibody (V2-179553) (CBMAB-A0870-YC)
-
Mouse Anti-BIRC7 Recombinant Antibody (88C570) (CBMAB-L0261-YJ)
-
Mouse Anti-HTLV-1 gp46 Recombinant Antibody (CBMW-H1006) (CBMAB-V208-1154-FY)
-
Mouse Anti-ALB Recombinant Antibody (V2-363290) (CBMAB-S0173-CQ)
-
Mouse Anti-C4B Recombinant Antibody (CBYY-C2996) (CBMAB-C4439-YY)
-
Mouse Anti-APC Recombinant Antibody (CBYC-A661) (CBMAB-A3036-YC)
-
Mouse Anti-ESR1 Recombinant Antibody (Y31) (CBMAB-1208-YC)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-ALPL Antibody (B4-78) (CBMAB-1009CQ)
-
Mouse Anti-AAV-5 Recombinant Antibody (V2-503417) (CBMAB-V208-1369-FY)
-
Mouse Anti-BBS2 Recombinant Antibody (CBYY-0253) (CBMAB-0254-YY)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-BrdU Recombinant Antibody (IIB5) (CBMAB-1038CQ)
-
Mouse Anti-AKT1 (Phosphorylated S473) Recombinant Antibody (V2-505430) (PTM-CBMAB-0067LY)
-
Rabbit Anti-B2M Recombinant Antibody (CBYY-0059) (CBMAB-0059-YY)
-
Rabbit Anti-CBL Recombinant Antibody (D4E10) (CBMAB-CP0149-LY)
By Hallmark/Pathway
The progression from neoplastic transformation to metastatic dissemination is governed by the acquisition of specific biological capabilities—the hallmarks of cancer. These phenotypic alterations, ranging from sustained proliferative signaling to the evasion of immune destruction, are underpinned by profound dysregulation within intracellular kinase networks and transcriptional machinery. Contemporary research emphasizes the need to dissect these pathways not in isolation, but as integrated circuits that drive tumor heterogeneity and therapeutic resistance.
Targeting these mechanisms requires tools of exceptional specificity. Whether investigating the "angiogenic switch" mediated by hypoxic gradients or delineating the epithelial-mesenchymal transition (EMT) axis that facilitates invasion, the fidelity of molecular detection is paramount. Our portfolio is systematically organized to address these critical research nodes, offering validated antibodies and assays designed to interrogate cell cycle checkpoints, apoptotic thresholds, vascular remodeling, and the immunosuppressive tumor microenvironment with high-resolution precision.
Browse by Hallmark/Pathway
Select a pathway to explore targets, antibodies, and validation data.
Loading...
Compare
